http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112972421-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5169 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 |
filingDate | 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112972421-B |
titleOfInvention | Nano-drug system based on multi-positive charge protein, preparation method and application thereof |
abstract | The invention provides a nano-drug system based on multi-positive charge protein, which comprises a nano-protein compound and a drug wrapped in the nano-protein compound; the nano-protein complex is formed by a multi-positive charged protein and a negatively charged polymer surfactant. Compared with the prior art, the nano-drug system provided by the invention directly takes the multi-positive charge protein as the core, and the polymer surfactant with negative charges and the drug are combined on the multi-positive charge protein to obtain the nano-drug system with high biocompatibility, so that the nano-drug system can be slowly released in vivo when being used for treating tumors, particularly bone cancer and metastatic cancer thereof, the drug effect is prolonged, the side effect is obviously reduced, and the nano-drug system has better medical prospect. |
priorityDate | 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.